Anna Lechanteur

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Venues

Pharmaceutics

Molecular pharmaceutics

Artificial cells, nanomedicine, and biotechnology

Nanomaterials (Basel, Switzerland)

Laboratory of Pharmaceutical Technology and Biopharmacy, University of Liege (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Laboratory of Pharmaceutical Technology and Biopharmacy, University of Liege

Belgium

PHD

INEB Oct 15 2016

Portugal

PHD :: Instituto de Engenharia Biomédica, Universidade do Porto

University of Liege Sep 15 2012 - Oct 01 2016

Belgium

PHD :: Laboratory of Pharmaceutical Technology and Biopharmacy

University of Liege

Belgium

MSC

Publications

Nathan Koch, Olivier Jennotte, Anna Lechanteur, Marine Deville, Corinne Charlier, Jean-Michel Cardot, Patrice Chiap, Brigitte Evrard
An Intravenous Pharmacokinetic Study of Cannabidiol Solutions in Piglets through the Application of a Validated Ultra-High-Pressure Liquid Chromatography Coupled to Tandem Mass Spectrometry Method for the Simultaneous Quantification of CBD and Its Carboxylated Metabolite in Plasma. Pharmaceutics 16 (1) (2024)
Nathan Koch, Olivier Jennotte, Anna Lechanteur, Marine Deville, Corinne Charlier, Jean-Michel Cardot, Patrice Chiap, Brigitte Evrard
An Intravenous Pharmacokinetic Study of Cannabidiol Solutions in Piglets through the Application of a Validated Ultra-High-Pressure Liquid Chromatography Coupled to Tandem Mass Spectrometry Method for the Simultaneous Quantification of CBD and Its Carboxylated Metabolite in Plasma. Pharmaceutics 16 (1) (2024)
Nathan Koch, Olivier Jennotte, Anna Lechanteur, Marine Deville, Corinne Charlier, Jean-Michel Cardot, Patrice Chiap, Brigitte Evrard
An Intravenous Pharmacokinetic Study of Cannabidiol Solutions in Piglets through the Application of a Validated Ultra-High-Pressure Liquid Chromatography Coupled to Tandem Mass Spectrometry Method for the Simultaneous Quantification of CBD and Its Carboxylated Metabolite in Plasma. Pharmaceutics 16 (1) (2024)
Manon Berger, Manon Degey, Jeanne Leblond Chain, Erik Maquoi, Brigitte Evrard, Anna Lechanteur, Géraldine Piel
Effect of PEG Anchor and Serum on Lipid Nanoparticles: Development of a Nanoparticles Tracking Method. Pharmaceutics 15 (2) (2023)
Manon Berger, Manon Degey, Jeanne Leblond Chain, Erik Maquoi, Brigitte Evrard, Anna Lechanteur, Géraldine Piel
Effect of PEG Anchor and Serum on Lipid Nanoparticles: Development of a Nanoparticles Tracking Method. Pharmaceutics 15 (2) (2023)
Manon Berger, Manon Degey, Jeanne Leblond Chain, Erik Maquoi, Brigitte Evrard, Anna Lechanteur, Géraldine Piel
Effect of PEG Anchor and Serum on Lipid Nanoparticles: Development of a Nanoparticles Tracking Method. Pharmaceutics 15 (2) (2023)
Manon Berger, Manon Degey, Jeanne Leblond Chain, Erik Maquoi, Brigitte Evrard, Anna Lechanteur, Géraldine Piel
Effect of PEG Anchor and Serum on Lipid Nanoparticles: Development of a Nanoparticles Tracking Method. Pharmaceutics 15 (2) (2023)
Isabela Angeli de Lima, Najeh Maissar Khalil, Tania Toyomi Tominaga, Anna Lechanteur, Bruno Filipe Carmelino Cardoso Sarmento, Rubiana Mara Mainardes
Mucoadhesive chitosan-coated PLGA nanoparticles for oral delivery of ferulic acid. Artificial cells, nanomedicine, and biotechnology 46 (sup2) (2018)
Anna Lechanteur, Vincent Sanna, Amandine Duchemin, Brigitte Evrard, Denis Mottet, Géraldine Piel
Cationic Liposomes Carrying siRNA: Impact of Lipid Composition on Physicochemical Properties, Cytotoxicity and Endosomal Escape. Nanomaterials (Basel, Switzerland) 8 (5) (2018)
Anna Lechanteur, Tania Furst, Brigitte Evrard, Philippe Delvenne, Géraldine Piel, Pascale Hubert
Promoting Vaginal Distribution of E7 and MCL-1 siRNA-Silencing Nanoparticles for Cervical Cancer Treatment. Molecular pharmaceutics 14 (5) (2017)

Anna Lechanteur.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Anna Lechanteur